Barclays
LONA

Barclays’s LeonaBio Inc LONA Stock Holding History

Barclays’s Portfolio LONA Stock Details LONA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$386 Buy
+42
New +$391 ﹤0.01% 5042
2025
Q4 		– Sell
-7
Closed -$29 – 5237
2025
Q3 		$29 Buy
+7
New +$27 ﹤0.01% 5341
2025
Q2 		– Hold
0
– – – 5194
2025
Q1 		– Sell
-4
Closed -$18 – 5222
2024
Q4 		$22 Sell
4
-97
-96% -$547 ﹤0.01% 5216
2024
Q3 		$452 Sell
101
-10,206
-99% -$239K ﹤0.01% 5149
2024
Q2 		$273K Sell
10,307
-2,860
-22% -$67.4K ﹤0.01% 3397
2024
Q1 		$361K Sell
13,167
-4,197
-24% -$133K ﹤0.01% 3786
2023
Q4 		$422K Sell
17,364
-26,220
-60% -$465K ﹤0.01% 3990
2023
Q3 		$880K Buy
43,584
+21,693
+99% +$556K ﹤0.01% 2422
2023
Q2 		$646K Sell
21,891
-1,721
-7% -$49K ﹤0.01% 2592
2023
Q1 		$590K Buy
23,612
+2,803
+13% +$90.3K ﹤0.01% 3151
2022
Q4 		$660K Buy
20,809
+4,132
+25% +$130K ﹤0.01% 3122
2022
Q3 		$495K Buy
16,677
+10,843
+186% +$374K ﹤0.01% 2712
2022
Q2 		$177K Sell
5,834
-278
-5% -$25.5K ﹤0.01% 3502
2022
Q1 		$826K Buy
+6,112
New +$644K ﹤0.01% 2548

Other funds holding LONA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
SSC
Spruce Street Capital New York $510M AUM
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Barclays's LONA Position: Q2 2026 in Review

Barclays opened a new position in LeonaBio Inc (LONA) in Q2 2026: 42 shares worth $386. The stake represents ﹤0.01% of the portfolio and ranks #5042 among its holdings. This is a return to the name: Barclays previously reported a position in LONA as recently as Q3 2025.

Barclays first reported a position in LONA in Q1 2022 and has held it in 14 quarters since. The position peaked at $880K in Q3 2023. 44 funds tracked by Wall St. Rank hold LONA as of Q2 2026.

  • Barclays held 42 shares of LeonaBio Inc worth $386 as of Q2 2026.
  • LeonaBio Inc was a new Barclays position in Q2 2026.
  • LeonaBio Inc made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #5042 holding.
  • Barclays first reported a position in LeonaBio Inc in Q1 2022 and has held it in 14 quarters since.
  • Barclays's LeonaBio Inc position peaked at $880K in Q3 2023.
  • 44 funds tracked by Wall St. Rank held LeonaBio Inc as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.